Liu Xiaoli, Yuan Lin, Li Dan, Tang Zengchao, Wang Yanwei, Chen Gaojian, Chen Hong, Brash John L
The Key Lab of Health Chemistry and Molecular Diagnosis of Suzhou, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, P. R. China.
J Mater Chem B. 2014 Sep 21;2(35):5718-5738. doi: 10.1039/c4tb00881b. Epub 2014 Aug 1.
Devices that function in contact with blood are ubiquitous in clinical medicine and biotechnology. These devices include vascular grafts, coronary stents, heart valves, catheters, hemodialysers, heart-lung bypass systems and many others. Blood contact generally leads to thrombosis (among other adverse outcomes), and no material has yet been developed which remains thrombus-free indefinitely and in all situations: extracorporeally, in the venous circulation and in the arterial circulation. In this article knowledge on blood-material interactions and "thromboresistant" materials is reviewed. Current approaches to the development of thromboresistant materials are discussed including surface passivation; incorporation and/or release of anticoagulants, antiplatelet agents and thrombolytic agents; and mimicry of the vascular endothelium.
在临床医学和生物技术领域,与血液接触发挥功能的设备无处不在。这些设备包括血管移植物、冠状动脉支架、心脏瓣膜、导管、血液透析器、体外循环系统等等。血液接触通常会导致血栓形成(以及其他不良后果),目前尚未开发出在所有情况下(体外、静脉循环和动脉循环)都能无限期保持无血栓的材料。本文综述了关于血液 - 材料相互作用和“抗血栓”材料的知识。讨论了当前开发抗血栓材料的方法,包括表面钝化;抗凝剂、抗血小板剂和溶栓剂的掺入和/或释放;以及对血管内皮的模拟。